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Abstract
Twenty-two carbapenem-resistant enterobacterial isolates were
recovered from patients hospitalized between October 2010
and March 2011 at the Royal Hospital of Muscat, Sultanate of
Oman. Eleven NDM-1, ﬁve OXA-48 and one NDM-1 plus
OXA-181 producers of diverse ST types were recovered from
clinical samples. All carbapenemase genes were located on self-
conjugative plasmids and were nearly always associated with
other resistance determinants, including extended-spectrum
b-lactamases and the ArmA methylase encoding resistance to
aminoglycosides. This work highlights the dissemination of
NDM-1 and OXA-48-type producers in the Middle East.
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Carbapenem-hydrolysing b-lactamases belonging to Ambler
classes A, B and D have been reported worldwide among En-
terobacteriaceae. The most clinically signiﬁcant are KPC-type
(Ambler class A), IMP-, VIM- and NDM-types (class B) and
OXA-48 (class D), mostly identiﬁed in Klebsiella pneumoniae
isolates as sources of nosocomial outbreaks [1].
Since its ﬁrst identiﬁcation from a K. pneumoniae isolate
recovered in Turkey in 2003 [2], OXA-48 producers have
been found worldwide, especially in Europe and in countries
bordering the southern and eastern parts of the Mediterra-
nean sea [1]. Several studies performed on OXA-48-produc-
ing strains revealed that the acquisition of a conserved
62.5-kilobases plasmid was at the origin of the dissemination
of blaOXA-48 in a variety of enterobacterial species, particu-
larly in K. pneumoniae and Escherichia coli [3]. In addition, a
variant of OXA-48, named OXA-181 and sharing a similar
carbapenemase activity, has been identiﬁed in isolates from
India or of Indian origin [4–7] with, in some cases, co-occur-
rence of other carbapenemases such as NDM-1 [6].
Producers of NDM-1 have been identiﬁed mainly in the
UK, India and Pakistan [8], and are being increasingly
reported worldwide [9]. Whereas India was considered as
the main reservoir of the NDM-1-encoding gene [9], several
NDM-1-producing enterobacterial isolates have been
reported from the Balkan states [10] and the Middle East
[11], suggesting that these areas might also be reservoirs of
NDM-1 producers.
Our study was perfomed on a collection of bacterial iso-
lates recovered at the Royal Hospital, Muscat, Sultanate of
Oman, that had been elaborated for the purpose of
surveillance of antimicrobial resistance mechanisms and
characterization of carbapenem-resistant strains. Twenty-two
multidrug-resistant Enterobacteriaceae (16 K. pneumoniae, four
E. coli, one Serratia marcescens and one Enterobacter cloacae)
isolated over a 5.5-month period (October 2010 to March
2011) were selected, all showing decreased susceptibility to
carbapenems. The isolates were recovered from clinical sam-
ples obtained from patients who had been hospitalized in vari-
ous units of the hospital (Table 1). PCR assays followed by
sequencing were carried out for the detection of several
carbapenemase genes, namely blaKPC, blaVIM, blaIMP, blaNDM
and blaOXA-48. Ten K. pneumoniae and one E. coli were posi-
tive for blaNDM-1 (Table 1). Two K. pneumoniae and three
E. coli were positive for blaOXA-48 (Table 1). One K. pneumo-
niae isolate co-harboured the blaNDM-1 and blaOXA-181 genes
(Table 1). History of travel in India could be traced for four
patients from whom NDM-1-producing K. pneumoniae had
been recovered (Table 1). For three isolates (one S. marces-
cens, one Enterobacter cloacae and one K. pneumoniae), no
carbapenemase activity nor carbapenemase genes were
identiﬁed, suggesting a non-carbapenemase-related resis-
tance mechanism. Instead, there were probably combined
mechanisms such as overproduction of the chromosomal
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cephalosporinase or extended-spectrum b-lactamase associ-
ated with decreased permeability of the outer membrane.
The twenty carbapenemase-producing isolates (16 K. pneu-
moniae and four E. coli) were subjected to pulsed-ﬁeld gel
electrophoresis analysis to evaluate their clonal relationship,
as previously described [11]. This analysis identiﬁed nine
clones of K. pneumoniae and three clones of E. coli (Table 2).
For each clone, MICs were determined by Etest (AB bio-
Me´rieux, Solna, Sweden) on Mueller–Hinton agar and the
results of susceptibility testing were interpreted according to
the CLSI guidelines [12]. The isolate co-producing NDM-1
and OXA-181 was fully resistant to all carbapenems, whereas
all OXA-48-producing isolates harboured an apparent suscep-
tibility to carbapenems (MICs £1 mg/L), making it difﬁcult to
detect with only a slight increase in carbapenem MICs
(Table 2). On the other hand, NDM-1-producing isolates
exhibited a variable susceptibility to carbapenems. As fre-
quently observed for carbapenemase producers, multi-drug
or pan-drug resistance was often associated. In our collection,
only one isolate, an OXA-48-producing K. pneumoniae, did
not possess a multi-drug resistance phenotype (Table 2).
Multi-locus sequence typing analysis was performed on
carbapenemase-producing K. pneumoniae and E. coli isolates.
Among the NDM-1-producing K. pneumoniae, ﬁve different
ST types were identiﬁed, showing that diverse NDM-1-posi-
tive strain backgrounds circulated in the same hospital
(Table 2). Two of these isolates belonged to ST147, which
had been previously identiﬁed among NDM-1-producing iso-
lates from Switzerland and Iraq, respectively [13,14]. An
NDM-1-producing K. pneumoniae belonging to ST15 was also
identiﬁed, as reported in Norway [15]. The single K. pneumo-
niae isolate co-producing NDM-1 and OXA-181 belonged to
ST11, which had been previously identiﬁed in India [6]. The
two OXA-48-producing K. pneumoniae belonged to two new
STs (ST753 and ST754, respectively).
Mating-out assays was performed using clinical strains as
donors and the azide-resistant E. coli J53 as recipient strain
[7], and E. coli transconjugants were obtained for all donor
strains (Table 2). Plasmid DNA of transconjugants was
extracted by using the Kieser method [16], analysed by aga-
rose gel electrophoresis and typed using PCR-based replicon
typing [17]. In addition, the recently identiﬁed IncHI1B repli-
con type was sought by using recently designed primers
(IncHI1B-Fw: 5¢ - CAA AAC AGA GAG TAT TCA ACC C -
3¢, ncHI1B-Rv: 5’ - CTG ATT CTT TTC GAG ACA GGG -
3¢). The blaNDM-1-positive plasmids belonged to diverse
incompatibility groups (Table 2). Most of those plasmids
belonged to the newly identiﬁed IncHI1B group, which has
been identiﬁed from NDM-1-producing K. pneumoniae from
Morocco [18]. Most often, several resistance markers were
co-harboured by the plasmid that carried the blaNDM-1 gene
(Table 2). In all isolates except one, the blaOXA-48 gene was
carried on a self-conjugative plasmid (62.5 kilobases) that
possesses an IncL/M-type backbone on which no other anti-
biotic resistance gene was identiﬁed (Table 2), and corre-
sponding to the epidemic plasmid identiﬁed worldwide [3].
The blaOXA-181 gene was carried on an untypable and non-
conjugative plasmid.
The PCR mapping showed that the blaNDM-1 gene was pre-
ceded by a complete or truncated copy of insertion sequence
ISAba125 and followed by a bleomycin-resistance gene bleMBL,
conferring resistance to bleomycin and bleomycin-like mole-
cules [19]. The same genetic environment has been observed
for most NDM-1-positive enterobacterial isolates [20]. The
blaOXA-48 gene was bracketed by two IS1999 elements form-
ing a functional composite transposon as previously described
[2]. The blaOXA-181 gene was located downstream on the
insertion sequence ISEcp1 as described [7].
In conclusion, this study highlights the dissemination of
carbapenemase producers, especially NDM-1 and OXA-48-
types, in Sultanate of Oman. Emergence of those carbape-
nemase producers in that country might be related to the
close relationship between the Arab Peninsula and India in
terms of patient exchange.
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